01 March 2005 : Original article
Segregation of the marker chromosome der(20) in the sperm of a male with karyotype 46,XY[961/ 47,XY+mar[4].
Ewa Wiland, Małgorzata Jarmuż, Maciej KurpiszMed Sci Monit 2005; 11(3): CS9-15 :: ID: 15392
Abstract
BACKGROUND: The influence of the marker chromosome on reproductive failure is difficult to assess, especially in the case of low-rate mosaicism. The aim of our work was to examine the meiotic segregation of the marker chromosome der(20) in the sperm of a normal male whose wife had experienced three miscarriages, and therefore to determine whether there occurred a gametogenic tissue-specific mosaicism. MATERIAL/METHODS: The proband was a phenotypically normal 35-year-old man, referred for pre-conceptional counseling after his wife had experienced three miscarriages. Chromosome cytogenetic analysis was performed on peripheral blood lymphocytes using routine protocols. Sperm chromosome complements were obtained after penetration of zona-free hamster oocytes. Dual-color FISH analysis was performed using directly labeled probes identifying X, Y, 9 and 20 chromosomes. RESULTS: A small marker chromosome der(20) was identified in 4% of the proband's lymphocytes and 8.25% of his sperm, which indicated mosaicism among the gametogenic cells, in which the proportion of cells containing the der(20) marker may reach a minimum of approx. 16%. CONCLUSIONS: In this case, we addressed a problem whether a revealed marker der(20) was the cause of reproductive failure or just a coincidental finding. In our view, each case of low-rate mosaicism of the marker chromosome should be individually assessed.
Keywords: Chromosome Segregation, Genetic Markers, In Situ Hybridization, Fluorescence, Karyotyping, Lymphocytes - cytology, Meiosis, Mosaicism, Spermatozoa - cytology, Chromosome Segregation, Genetic Markers, In Situ Hybridization, Fluorescence, Karyotyping, Lymphocytes - cytology, Meiosis, Mosaicism, Spermatozoa - cytology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952